Skip to content

Haemonetics HAE Raw materials

Raw materials at other companies

Abbott logo
AbbottABT
$1.72B+2.1%
TFX
TeleflexTFX
$89.62M-47.4%
LivaNova logo
LivaNovaLIVN
$72.31M+0.6%
ICU Medical logo
ICU MedicalICUI
$268.09M-5.1%
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's raw materials?
Haemonetics (HAE) reported raw materials of $114.32M in Q4 2025.
How has Haemonetics's raw materials changed year-over-year?
Haemonetics's raw materials increased by 12.1% year-over-year, from $101.99M to $114.32M.
What is the long-term trend for Haemonetics's raw materials?
Over 4 years (2021 to 2025), Haemonetics's raw materials has grown at a 14.5% compound annual growth rate (CAGR), from $74.91M to $128.57M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.